to have a drug that is the gold standard that is available through discrete, specific channels, and then to say that a 5,000 percent price increase is necessary to invest in the means to reach that captive patient population just seems to defy common sense.
Blumenthal argues that a price increase contradicts the goal of making a drug accessible.
Share
More from Richard Blumenthal
This $14.6 million federal investment will transform a dangerous intersection into a safer, more welcoming, and efficient gateway for everyone who uses it while strengthening access to CTfastrak and supporting economic growth.
Other voices in this conversation
